MPC-4326
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MPC-4326, covering 2010-01-06 to 2010-06-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy [Phase 2]